PSIL
PSIL
About AdvisorShares Psychedelics ETF
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such...
About AdvisorShares Psychedelics ETF
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 ATAI | Atai Beckley N.V | 10.54% | 567.59K | $2.17M |
 CMPS | COMPASS Pathways plc | 10.27% | 255.74K | $2.11M |
 DFTX | Definium Therapeutics, Inc. | 9.14% | 108.90K | $1.88M |
 RLMD | Relmada Therapeutics, Inc. | 7.18% | 338.87K | $1.48M |
 ALKS | Alkermes plc | 6.89% | 44.27K | $1.42M |
 GHRS | GH Research PLC | 6.09% | 79.33K | $1.25M |
 NBIX | Neurocrine Biosciences, Inc. | 5.61% | 8.87K | $1.15M |
 HELP | Cybin Inc. Common Stock | 5.42% | 161.60K | $1.12M |
 ANRO | Alto Neuroscience, Inc. | 5.39% | 56.82K | $1.11M |
 DRUG | Bright Minds Biosciences Inc. | 4.94% | 11.81K | $1.02M |
 SUPN | Supernus Pharmaceuticals, Inc. | 4.86% | 19.45K | $998.91K |
 ABBV | AbbVie Inc. | 4.11% | 3.77K | $844.68K |
 JNJ | Johnson & Johnson | 4.06% | 3.38K | $834.06K |
 NRXP | NRx Pharmaceuticals, Inc. | 3.31% | 370.47K | $681.66K |
 NEUP | Neuphoria Therapeutics Inc. | 3.10% | 148.63K | $637.61K |
 STIM | Neuronetics, Inc. | 2.23% | 342.19K | $458.54K |
 KTTA | Pasithea Therapeutics Corp. | 1.31% | 337.51K | $269.57K |
 QNTM | Quantum BioPharma Ltd. | 1.15% | 63.59K | $236.56K |
 IXHL | Incannex Healthcare Limited | 1.01% | 735.10K | $206.93K |
 SILO | Silo Pharma, Inc. | 0.95% | 663.97K | $195.80K |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
Ireland
Canada
Netherlands
United Kingdom
AustraliaSECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States Ireland Canada Netherlands United Kingdom AustraliaHoldings (Top 20)
ATAI
Atai Beckley N.V
CMPS
COMPASS Pathways plc
DFTX
Definium Therapeutics, Inc.
RLMD
Relmada Therapeutics, Inc.
ALKS
Alkermes plc
GHRS
GH Research PLC
NBIX
Neurocrine Biosciences, Inc.
HELP
Cybin Inc. Common Stock
ANRO
Alto Neuroscience, Inc.
DRUG
Bright Minds Biosciences Inc.
SUPN
Supernus Pharmaceuticals, Inc.
ABBV
AbbVie Inc.
JNJ
Johnson & Johnson
NRXP
NRx Pharmaceuticals, Inc.
NEUP
Neuphoria Therapeutics Inc.
STIM
Neuronetics, Inc.
KTTA
Pasithea Therapeutics Corp.
QNTM
Quantum BioPharma Ltd.
IXHL
Incannex Healthcare Limited
SILO
Silo Pharma, Inc.